ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/SRR141/021/SRR14130121/SRR14130121_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR141/020/SRR14130120/SRR14130120_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR141/021/SRR14130121/SRR14130121_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR141/020/SRR14130120/SRR14130120_2.fastq.gzprimaryOK200GenomicsShanghai Jiaotong Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA719120Homo sapiensE2F6 plays oncogenic roles and in order to identify the molecular mechanism of E2F6 to promote tumorigenesis, RNA-seq was performed on Huh7 cells with or without E2F6. Overall design: Huh7 cell were transfected with E2F6 shRNA. After E2F6 was knocked down, total RNA was isolated and subjected to RNA-seq.ENAdTAF[[II]]60, TAF10b, d110, dTAFII30beta, d230, Taf[[II]]150, dTAF[[II]]150, l(3)72Dj, taf24, Taf60-2, CG3069, dTAFII250, TAF[II]150, CG10390, dTAF10, dtafII24, EfW1, dTAF[[II]]62, dTAFII24, d60, DmelCG5444, II, DmelCG4079, DmelCG10390, dmTAF[[II]]230, Mia, E2F-6, dTAF[[II]]262, dmTAF1, Taf110, Taf230, p62, dmTAF6, dTAF150, dTAF[[II]]60-2, dmTAF4, DmelCG2859, Taf-6, Whole Transcriptome Shotgun Sequencing, TAFII60(62), Taf62, Taf60, TAF250, TAF[[II]]150, Taf200, dTAF[[II]]250, TFIID TAF250, dTAF6L, cel, cell, DmelCG32211, dTAF[[II]]30beta, TAF60, TAFII16, AI462434, CG6711, Taf1p, TFIID 28 beta, TAF[[II]]60, dTAFII150, IGFBP-7v, TAF[[II]]62, CG32211, dTAF250, TAFII150, IBP-7, TFIID 110, dTAF62, SY3-2 TAF110, TAF, TAF150, SR3-4B, TAF[II]30beta, dTAF[[II]]30, 43, TFIID-p28beta, Taf[[II]]110, TAFII-43, TAF60/62, taf60, data, dTAF[[II]]110, dTAF[[II]]230, TAF[[II]]250, TAF30b, MAC25 protein, TafII24, taf6, Taf[[II]]30beta, TAF[II]110, dmTAF6b, TAF200, p110, Taf16, RNA-seq, l(3)84Ab, dTAF10b, CG5444, Taf[[II]]60, BG:DS00004.13, dTAF4, CG4079, EMA, dTAF[[II]]24, TAFII-250, dTAFII62, TAF250/230, CG2859, PGI2-stimulating factor, Cell, Huh7, dTAF230, TAFII60, dme-TAFII60, TBN, Prostacyclin-stimulating factor, PSF, TAFII250, TFIID 62, TAFII62, DmelCG3069, IGFBP-7, RAMSVPS, p230, Taf150, dTAFII30 beta, taf110, TAF[[II]]250/230, TAF6L, TFIID, TAF60-2, IGFBP-rP1, TAF[[II]]16, TAF[[II]]30beta, dTAF[[II]]16, Taf24, dTAF II 150, BcDNA:RE73934, Taf[[II]]250, dmTAF10, Taf6L, TAF[[II]]110, ms(3)570, TAF[[II]]230, TafII150, FSTL2, TAF[[II]]24, l(3)76BDf, dmTaf10, CG9348, TAF[II]250, dTAFII110, IGF-binding protein 7, CG17603, TAF[[II]], TAF[[II]]60/62, dmTAF10b, Taf30beta, E2F6b, DmelCG17603, TAFII110, TAF10, DmelCG6711, TAF11, AGM, Huh-7, TAF30beta, TAF1., Taf250, dTAF6, Tumor-derived adhesion factor, MAC25, SR3-5, TAFII43, SR3-3, TAF[[II]]60-2, TafII16, dtafII16, IGFBPRP1, d30beta, TAF6, dTAFII30, TAF110, TAF4, TAF230, TAF2dTAF[[II]]60, TAF10b, d110, dTAFII30beta, d230, Taf[[II]]150, dTAF[[II]]150, l(3)72Dj, taf24, Taf60-2, CG3069, dTAFII250, TAF[II]150, CG10390, dTAF10, dtafII24, EfW1, dTAF[[II]]62, dTAFII24, d60, DmelCG5444, II, DmelCG4079, DmelCG10390, dmTAF[[II]]230, Mia, E2F-6, dTAF[[II]]262, dmTAF1, Taf110, Taf230, p62, dmTAF6, dTAF150, dTAF[[II]]60-2, dmTAF4, DmelCG2859, Taf-6, Whole Transcriptome Shotgun Sequencing, TAFII60(62), Taf62, Taf60, TAF250, TAF[[II]]150, Taf200, dTAF[[II]]250, TFIID TAF250, dTAF6L, cel, cell, DmelCG32211, dTAF[[II]]30beta, TAF60, TAFII16, AI462434, CG6711, Taf1p, TFIID 28 beta, TAF[[II]]60, dTAFII150, IGFBP-7v, TAF[[II]]62, CG32211, dTAF250, TAFII150, IBP-7, TFIID 110, dTAF62, SY3-2 TAF110, TAF, TAF150, SR3-4B, TAF[II]30beta, dTAF[[II]]30, 43, TFIID-p28beta, Taf[[II]]110, TAFII-43, TAF60/62, taf60, data, dTAF[[II]]110, dTAF[[II]]230, TAF[[II]]250, TAF30b, MAC25 protein, TafII24, taf6, Taf[[II]]30beta, TAF[II]110, dmTAF6b, TAF200, p110, Taf16, RNA-seq, l(3)84Ab, dTAF10b, CG5444, Taf[[II]]60, BG:DS00004.13, dTAF4, CG4079, EMA, dTAF[[II]]24, TAFII-250, dTAFII62, TAF250/230, CG2859, PGI2-stimulating factor, Cell, Huh7, dTAF230, TAFII60, dme-TAFII60, TBN, Prostacyclin-stimulating factor, PSF, TAFII250, TFIID 62, TAFII62, DmelCG3069, IGFBP-7, RAMSVPS, p230, Taf150, dTAFII30 beta, taf110, TAF[[II]]250/230, TAF6L, TFIID, TAF60-2, IGFBP-rP1, TAF[[II]]16, TAF[[II]]30beta, dTAF[[II]]16, Taf24, dTAF II 150, BcDNA:RE73934, Taf[[II]]250, dmTAF10, Taf6L, TAF[[II]]110, ms(3)570, TAF[[II]]230, TafII150, FSTL2, TAF[[II]]24, l(3)76BDf, dmTaf10, CG9348, TAF[II]250, dTAFII110, IGF-binding protein 7, CG17603, TAF[[II]], TAF[[II]]60/62, dmTAF10b, Taf30beta, E2F6b, DmelCG17603, TAFII110, TAF10, DmelCG6711, TAF11, AGM, Huh-7, TAF30beta, TAF1., Taf250, dTAF6, Tumor-derived adhesion factor, MAC25, SR3-5, TAFII43, SR3-3, TAF[[II]]60-2, TafII16, dtafII16, IGFBPRP1, d30beta, TAF6, dTAFII30, TAF110, TAF4, TAF230, TAF20.00.00.00.00.0falseRNA-seq data for E2F6 knockdown in Huh7 cellsRNA-seq data for E2F6 knockdown in Huh7 cells2022-05-122021-04-11PRJNA719120GSE171319343398009606